First biosimilar marketing initiatives by MCOs in U.S. 2015

Planned initiatives of managed care organizations (MCOs) after first biosimilar is marketed in the United States as of 2015

by Statista Research Department, last edited May 6, 2016
First biosimilar marketing initiatives by MCOs in U.S. 2015 This survey depicts the initiatives managed care organizations (MCOs) are planning to undertake when the first biosimilar is marketed in the United States, as of 2015. The survey shows that 93 percent of MCOs plan to undergo a review by the pharmacy and therapeutics committee.
Show more

Planned initiatives of managed care organizations (MCOs) after first biosimilar is marketed in the United States as of 2015

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Cancer in the U.S."
  • Overview
The most important statistics
  • Incidence rates
  • Death rates
  • Probability of surviving
  • Risk factors
  • Cancer drug market
  • Miscellaneous
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.